4.7 Review

Antimicrobial Activity of Human Fetal Membranes: From Biological Function to Clinical Use

Journal

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2021.691522

Keywords

fetal membrane; perinatal derivatives; amniotic membrane; amnio-chorionic membrane; placenta; antimicrobial peptides; bacteria; antibacterial activity

Funding

  1. Slovenian Research Agency [J7-2594, P3-0108, P1-0198]
  2. MRIC UL IP-0510 Infrastructure program

Ask authors/readers for more resources

The fetal membranes provide a supportive environment for the embryo and fetus and have gained attention for their antimicrobial properties in recent years. Antimicrobial peptides secreted by perinatal derivatives contribute to a healthy pregnancy and the prevention of complications. Research on the antimicrobial properties of fetal membranes and their derivatives has provided valuable insights for potential clinical applications, emphasizing the importance of standardization in preparation, testing methods, in vivo studies, and donor selection criteria.
The fetal membranes provide a supportive environment for the growing embryo and later fetus. Due to their versatile properties, the use of fetal membranes in tissue engineering and regenerative medicine is increasing in recent years. Moreover, as microbial infections present a crucial complication in various treatments, their antimicrobial properties are gaining more attention. The antimicrobial peptides (AMPs) are secreted by cells from various perinatal derivatives, including human amnio-chorionic membrane (hACM), human amniotic membrane (hAM), and human chorionic membrane (hCM). By exhibiting antibacterial, antifungal, antiviral, and antiprotozoal activities and immunomodulatory activities, they contribute to ensuring a healthy pregnancy and preventing complications. Several research groups investigated the antimicrobial properties of hACM, hAM, and hCM and their derivatives. These studies advanced basic knowledge of antimicrobial properties of perinatal derivatives and also provided an important insight into the potential of utilizing their antimicrobial properties in a clinical setting. After surveying the studies presenting assays on antimicrobial activity of hACM, hAM, and hCM, we identified several considerations to be taken into account when planning future studies and eventual translation of fetal membranes and their derivatives as antimicrobial agents from bench to bedside. Namely, (1) the standardization of hACM, hAM, and hCM preparation to guarantee rigorous antimicrobial activity, (2) standardization of the antimicrobial susceptibility testing methods to enable comparison of results between various studies, (3) investigation of the antimicrobial properties of fetal membranes and their derivatives in the in vivo setting, and (4) designation of donor criteria that enable the optimal donor selection. By taking these considerations into account, future studies will provide crucial information that will enable reaching the optimal treatment outcomes using the fetal membranes and their derivatives as antimicrobial agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available